USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Attractiveness and Hurdles for Stakeholders in the Next 5 Years
The growing population base, driven by increased life expectancy and domestic investment, is expected to continuously accelerate GDP in Malaysia. Significant growth of healthcare expenditure is expected in the country to facilitate the improvement of medical access and provide companies with revenue-earning opportunities from 2015. Positive macroeconomic and healthcare market trends are expected to fast-track the pharmaceutical market in Malaysia. The study explores the broad competitive landscape, demand dynamics, and regulatory environment that investors must consider while entering this pharmaceutical market.
Key Findings
Key Questions this Study will Answer
Overview of the Malaysian Healthcare Market
Overview of the Malaysian Healthcare Market (continued)
Overview of the Malaysian Healthcare Market (continued)
Overview of the Malaysian Healthcare Market (continued)
Overview of the Malaysian Healthcare Market (continued)
Overview of the Malaysian Healthcare Market (continued)
Overview of the Malaysian Healthcare Market (continued)
Overview of Malaysian Public and Private Healthcare Systems
Overview of Malaysian Public and Private Healthcare Systems (continued)
Algorithm of Malaysian Healthcare Systems
Algorithm of Private Healthcare Systems
Future Roadblocks
Distribution of Household Income Up to 2012
Key Driver in the Malaysian Hospital Market—Growing Admission of Elderly Population
Key Driver in the Malaysian Private Hospital Segment—Medical Tourism
Key Drivers in the Malaysian Hospital Market—Chronic and Lifestyle Diseases
Overview of the Malaysian Pharmaceutical Market
Revenue Forecast for the Malaysian Pharmaceutical Market
Pharmaceutical Market Components by Percentage
Malaysian Pharmaceutical Market—Segmentation
Malaysian Pharmaceutical Market—Segmentation (continued)
Halal Medicine Market in Malaysia
Malaysian Regulatory Landscape
Key Driver in the Malaysian Pharmaceutical Market—NKEA
Impact of GST on Malaysian Pharmaceutical Market
Drivers
Restraints
Home-grown Participants in the Malaysian Pharmaceutical Market
CCM Pharmaceuticals Sdn Bhd
Kotra Pharma (M) Sdn Bhd
Pharmaniaga Berhad
YSP Industries (M) Sdn Bhd
Hovid Berhad
MNC Participants in the Malaysian Pharmaceutical Market
Pfizer Malaysia
Merck Sharp & Dohme (MSD)
Eli Lilly
GlaxoSmithKline (GSK)
Johnson & Johnson Sdn Bhd
PESTLE Analysis
Porter Five Forces Analysis for the Malaysian Pharmaceutical Market
The Future of the Malaysian Pharmaceutical Market—Key Focus Areas
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related industry research
17 Sep 2026 | Asia Pacific | Frost Radar
Frost Radar™: Facility Management in Malaysia, 2026
Malaysia's facility management (FM) market is transitioning from labor-intensive, compliance-driven service delivery to technology-enabled, outcome-oriented, and sustainability-integrated operating models. Competitive differentiation increasingly depends on providers’ ability to combine integrated F...
17 Sep 2026 | Global | Market Research
Growth Opportunities in the Western Europe Consumer eSIM Market, 2026–2029
The consumer eSIM market in Western Europe is growing steadily, supported by the rising availability of eSIM-capable devices, particularly smartphones, and expanding travel-related use cases. However, commercialization has yet to translate into mass adoption. Despite Apple’s global launch of an eSIM...
17 Sep 2026 | Asia Pacific | Frost Radar
Frost Radar™: ASEAN Warehouse Automation System Providers, 2026
Warehouse automation has moved from a discretionary capital project to a core operating capability. ASEAN operators are redesigning fulfillment networks around smaller orders, shorter delivery windows, broader stock keeping unit (SKU) ranges, and sharper demand volatility. Manual operations remain v...
16 Sep 2026 | North America | Customer Research
US Automotive Technicians’ Choice Survey, 2025
The 2025 US Automotive Technicians’ Choice study is an insightful voice-of-customer survey that highlights the tool preferences of automotive aftermarket service technicians. The survey of 400 automotive technicians across the United States used a combination of computer-assisted telephone and compu...
16 Sep 2026 | Global | Market Research
Apple Performance Tracker, Q1 2026
This Frost & Sullivan tracker provides metrics on Apple's quarterly performance (for both unit sales and revenues) for iPads, iPhones, Macs, and other products, such as iPods, Apple TVs, Beats Electronics, and Apple-branded and third-party accessories. It includes historical quarterly data for all t...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Lightbox Content | World Cancer Day 2019|Get 15% discount for all Healthcare studies |https://store.frost.com/contacts/?utm_source=PD&utm_medium=lightbox&utm_campaign=HEALTHCARE_CANCER2019 |
| Author | Rageshwary Ramupillai |
| WIP Number | 9AB9-00-22-00-00 |
| Is Prebook | No |